Cartica Acquisition Corp Warrant
Cartica Acquisition Corp does not have any significant operations. The company focuses on effecting a merger, share exchange, asset acquisition, share purchase, reorganization, or similar business combination with one or more businesses or entities. It intends to identify and complete a business combination in the technology sector. Cartica Acquisition Corp was incorporated in 2021 and is based i… Read more
Cartica Acquisition Corp Warrant (CITEW) - Net Assets
Latest net assets as of September 2024: $14.91 Million USD
Based on the latest financial reports, Cartica Acquisition Corp Warrant (CITEW) has net assets worth $14.91 Million USD as of September 2024.
Net assets (also known as shareholders' equity or book value) represent the difference between a company's total assets ($25.99 Million) and total liabilities ($11.07 Million). This figure indicates the residual interest in the assets after deducting liabilities, essentially showing what would remain for shareholders if all assets were liquidated and all debts paid off.
Key Net Assets Metrics
| Metric | Value |
|---|---|
| Current Net Assets | $14.91 Million |
| % of Total Assets | 57.39% |
| Annual Growth Rate | N/A |
| 5-Year Change | N/A |
| 10-Year Change | N/A |
| Growth Volatility | N/A |
Cartica Acquisition Corp Warrant - Net Assets Trend (2021–2023)
This chart illustrates how Cartica Acquisition Corp Warrant's net assets have evolved over time, based on quarterly financial data. Explore and compare other companies by net assets.
Annual Net Assets for Cartica Acquisition Corp Warrant (2021–2023)
The table below shows the annual net assets of Cartica Acquisition Corp Warrant from 2021 to 2023.
| Year | Net Assets | Change |
|---|---|---|
| 2023-12-31 | $44.60 Million | -80.72% |
| 2022-12-31 | $231.30 Million | +95134.36% |
| 2021-12-31 | $-243.39K | -- |
Equity Component Analysis
This analysis shows how different components contribute to Cartica Acquisition Corp Warrant's total equity over time. Equity components include common stock, retained earnings, additional paid-in capital, and other elements.
Equity Composition Insights
- Retained earnings have decreased by 472175500.0% over the analyzed period, potentially due to dividend distributions or operating losses.
Current Equity Component Breakdown (December 2023)
| Component | Amount | Percentage |
|---|---|---|
| Common Stock | $46.31 Million | 103.82% |
| Other Components | $3.29 Million | 7.37% |
| Total Equity | $44.60 Million | 100.00% |
Cartica Acquisition Corp Warrant Competitors by Market Cap
The table below lists competitors of Cartica Acquisition Corp Warrant ranked by their market capitalization.
| Company | Market Cap |
|---|---|
|
Sylla Gold Corp.
PINK:SYGCF
|
$586.29K |
|
Joshua Gold Resources Inc
PINK:JSHG
|
$586.43K |
|
Windtree Therapeutics Inc
NASDAQ:WINT
|
$586.68K |
|
Biofrontera Inc. Warrants
NASDAQ:BFRIW
|
$586.78K |
|
Premier Biomedical Inc
PINK:BIEI
|
$585.78K |
|
Fbec Worldwide
PINK:FBEC
|
$585.64K |
|
Colibri Resource Corporation
PINK:CRUCF
|
$585.48K |
|
NuGene International Inc
PINK:NUGN
|
$585.17K |
Equity Growth Attribution
This analysis shows how different factors contributed to changes in Cartica Acquisition Corp Warrant's equity between the two most recent reporting periods.
Equity Growth Insights
- From 2022 to 2023, total equity changed from 231,303,190 to 44,601,507, a change of -186,701,683 (-80.7%).
- Net income of 6,380,335 contributed positively to equity growth.
- Share repurchases of 200,917,798 reduced equity.
- Other factors increased equity by 7,835,780.
Equity Change Factors (2022 to 2023)
| Factor | Impact | Contribution |
|---|---|---|
| Net Income | $6.38 Million | +14.31% |
| Share Repurchases | $200.92 Million | -450.47% |
| Other Changes | $7.84 Million | +17.57% |
| Total Change | $- | -80.72% |
Book Value vs Market Value Analysis
This analysis compares Cartica Acquisition Corp Warrant's book value (net assets) with its market value over time. The relationship between these values can provide insights into investor sentiment and company valuation.
Valuation Insights
- Current price-to-book ratio: 0.12x
- The company is trading below its book value, potentially indicating the market believes the assets are overvalued on the balance sheet or anticipates future losses.
Historical Price-to-Book Ratios
| Date | Book Value per Share | Market Price | P/B Ratio |
|---|---|---|---|
| 2021-12-31 | $-0.01 | $0.26 | x |
| 2022-12-31 | $8.05 | $0.26 | x |
| 2023-12-31 | $2.24 | $0.26 | x |
Capital Efficiency Dashboard
This dashboard shows how efficiently Cartica Acquisition Corp Warrant utilizes its equity to generate returns, including Return on Equity (ROE) and its components based on the DuPont analysis framework.
Capital Efficiency Insights
- Current Return on Equity (ROE): 14.31%
- The company shows good efficiency in utilizing shareholder equity.
- DuPont Analysis Breakdown:
- • Net Profit Margin: 0.00%
- • Asset Turnover: 0.00x
- • Equity Multiplier: 1.04x
- Recent ROE (14.31%) is above the historical average (8.70%), indicating improving capital efficiency.
Historical Capital Efficiency Metrics
| Year | Return on Equity | Net Profit Margin | Asset Turnover | Equity Multiplier | Economic Value Added |
|---|---|---|---|---|---|
| 2021 | 0.00% | 0.00% | 0.00x | 0.00x | $-268.45K |
| 2022 | 11.79% | 0.00% | 0.00x | 1.04x | $4.14 Million |
| 2023 | 14.31% | 0.00% | 0.00x | 1.04x | $1.92 Million |
Industry Comparison
This section compares Cartica Acquisition Corp Warrant's net assets metrics with peer companies in the Shell Companies industry.
Industry Context
- Industry: Shell Companies
- Average net assets among peers: $36,677,338
- Average return on equity (ROE) among peers: -64.57%
Peer Company Comparison
| Company | Net Assets | Return on Equity | Debt-to-Equity | Market Cap |
|---|---|---|---|---|
| Cartica Acquisition Corp Warrant (CITEW) | $14.91 Million | 0.00% | 0.74x | $586.20K |
| Artius II Acquisition Inc. Class A Ordinary Shares (AACB) | $-60.27K | 0.00% | 0.00x | $198.37 Million |
| Artius II Acquisition Inc. Units (AACBU) | $-60.27K | 0.00% | 0.00x | $205.28 Million |
| Ares Acquisition Corporation II (AACT-UN) | $931.34 Million | 0.00% | 0.08x | $399.77 Million |
| AA Mission Acquisition Corp. (AAM-UN) | $-559.90 Million | 0.00% | 0.00x | $349.76 Million |
| Global Acquisitions Corporation (AASP) | $3.80 Million | -5.26% | 0.34x | $15.42 Million |
| ABV Consulting Inc (ABVN) | $8.75K | -623.31% | 2.50x | $461.96K |
| Atlantic Coastal Acquisition Corp II (ACAB) | $-8.52 Million | 0.00% | 0.00x | $2.44 Million |
| Annabidiol Corp (ACBD) | $-501.57K | 0.00% | 0.00x | $13.62K |
| ACRO Biomedical Co Ltd (ACBM) | $685.87K | -17.12% | 0.46x | $30.04K |
| Huaizhong Health Group Inc (ADAD) | $-19.47K | 0.00% | 0.00x | $3.15K |